Follow-up of cyclosporin A treatment in
✍
S. Martin; G. Schernthaner; J. Nerup; F. A. Gries; V. A. Koivisto; J. Dupré; E.
📂
Article
📅
1991
🏛
Springer
🌐
English
⚖ 541 KB
In the Canadian/European randomized controlled study on cyclosporin A (CsA) in recent onset Type 1 (insulin-dependent) diabetes, treatment with the immunosuppressive drug had increased and maintained Beta-cell function and clinical remission during the first 12 months. Following discontinuation of t